— The High Court had dismissed proceedings rather than adjourn because it could not see any realistic basis for overriding the 16-year-old's consent for cross-sex hormones. The Court of Appeal reversed that decision because: (1) Gender Plus, a private provider, could not satisfy all the Cass Review recommendations, including that every medical treatment case be considered by a national MDT; (2) the Cass Review had only just been published when the judge heard the application, and there was sufficient doubt as to what is proper and appropriate in this area.
Full details available at: https://www.mentalhealthlaw.co.uk/O_v_P_(2024)_EWCA_Civ_1577?id=140225-2111
1 Like